Skip to main content

Table 1 Summary of the laboratory data

From: Hepatic and lung methotrexate-associated polymorphic lymphoproliferative disorders arising during postoperative follow-up of renal cell carcinoma: a case report

Complete blood count

Alkaline phosphatase

157 IU/L (115–359 IU/L)

 White blood cells

65 × 102/μL (30–97 × 102/μL)

Blood-urea-nitrogen

11.0 mg/dL (7.4–19.5 mg/dL)

 Neutrophils

83.3% (36.6–79.9%)

Creatinine

0.71 mg/dL (0.5–1.2 mg/dL)

 Hemoglobin

11.4 g/dL (13.1–17.6 g/dL)

Total protein

6.61 g/dL (6.4–8.3 g/dL)

 Hematocrit

35.5% (38.1–50.8%)

Albumin

4.41 g/dL (3.8–5.2 g/dL)

 Platelet counts

35.6 × 104/μL (12.4–30.5 × 104/μL)

Na

142 mEq/L (135–147 mEq/L)

 Coagulation

 

K

4.6 mEq/L (3.4–4.8 mEq/L)

 PT-INR

0.99 (0.89–1.12)

Cl

104 mEq/L (98–110 mEq/L)

 APTT

28.0 seconds (23.6–31.3 seconds)

HbA1c

5.7% (4.6–6.2%)

Biochemistry

C-reactive protein

1.52 mg/dL

 Total bilirubin

0.8 mg/dL (0.1–1.2 mg/dL)

Tumor marker

 

 Aspartate aminotransferase

42 IU/L (12–35 IU/dL)

CEA

0.8 ng/mL (0–6 ng/mL)

 Alanine aminotransferase

39 IU/L (6–40 IU/L)

SCC

0.8 ng/mL (< 2.0 ng/mL)

 Lactate dehydrogenase

376 IU/L (119–229 IU/L)

KL-6

510 U/mL (< 500 U/mL)

 γ-glutamyl transpeptidase

71 IU/L (0–48 IU/L)

  
  1. PT-INR prothrombin time-international normalized ratio, Na sodium, APTT activated partial thromboplastin time, K potassium, Cl chlorine, HbA1c hemoglobinA1c, CEA carcinoembryonic antigen, SCC squamous cell carcinoma antigen, KL-6 sialylated carbohydrate antigen KL-6